Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Glaukos Corporation (GKOS)

49.52   -1.45 (-2.84%) 10-01 09:29
Open: 51.16 Pre. Close: 50.97
High: 51.5 Low: 48.71
Volume: 541,379 Market Cap: 2,212M
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. The company is headquartered in San Clemente, California and currently employs 437 full-time employees. The firm focuses on the development and commercialization of products and procedures for the treatment of glaucoma. The company offers iStent, a micro-invasive glaucoma surgery (MIGS) device. The iStent is a micro-bypass stent inserted through the small corneal incision made during cataract surgery and placed into Schlemm's canal, a circular channel in the eye that collects aqueous humor and delivers it back into the bloodstream. The company is developing three additional pipeline products: the iStent Inject, the iStent Supra and iDose. The iStent Inject includes two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is a drug delivery system that is designed to be implanted in the eye to continuously deliver therapeutic levels of medication for extended periods of time to lower intraocular pressure in glaucoma patients.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 52.035 - 52.216 52.216 - 52.382
Low: 49.653 - 49.885 49.885 - 50.096
Close: 50.841 - 51.166 51.166 - 51.462

Technical analysis

as of: 2020-09-30 4:42:04 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 60.77     One year: 70.98
Support: Support1: 44.64    Support2: 40.08
Resistance: Resistance1: 52.03    Resistance2: 60.77
Pivot: 48.49
Moving Average: MA(5): 48.86     MA(20): 48.22
MA(100): 42.16     MA(250): 48.26
MACD: MACD(12,26): 1.32     Signal(9): 1.25
Stochastic oscillator: %K(14,3): 81.51     %D(3): 67.07
RSI: RSI(14): 63.28
52-week: High: 70.96  Low: 23.31  Change(%): -11.9
Average Vol(K): 3-Month: 58160  10-Days: 67801

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
GKOS has closed above the upper band by 0.6%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 36.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 29 Sep 2020
NOTICE For Investors In NYSE: GKOS Shareholder Notice: Update in Lawsuit for Investors who held Avedro, Inc. (AVDR) shares announced by Shareholders Foundation - Yahoo Finance

Tue, 29 Sep 2020
Brokerages Anticipate Glaukos Corp (NYSE:GKOS) Will Post Quarterly Sales of $53.89 Million - MarketBeat

Sat, 26 Sep 2020
Investor confidence returns after Glaukos Corporation (NYSE:GKOS) share prices gain $1.27 - Marketing Sentinel

Mon, 14 Sep 2020
Glaukos Corporation (NYSE: GKOS) Shareholder Notice: Update in Lawsuit for Investors who held Avedro, Inc. (AVDR) shares announced by Shareholders Foundation - Yahoo Finance

Fri, 11 Sep 2020
Glaukos Corporation (GKOS) Touches $49.49: At This Price, The Risk Is Worth It - Stocks Register

Fri, 11 Sep 2020
Glaukos Corporation (GKOS) recent quarterly performance of 27.45% is not showing the real picture - News Daemon

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Medical Instruments & Supplies
Shares Out. (M) 45
Shares Float (M) 43
% Held by Insiders 3.21
% Held by Institutions 111.52
Shares Short (K) 6,720
Shares Short P. Month (K) 6,660

Stock Financials

EPS -1.720
EPS Est This Year -0.060
EPS Est Next Year 0.230
Book Value (p.s.) 14.870
Profit Margin -33.55
Operating Margin -36.45
Return on Assets (ttm) -7.4
Return on Equity (ttm) -16.7
Qtrly Rev. Growth -46.1
Gross Profit (p.s.) 4.531
Sales Per Share 4.729
EBITDA (p.s.) -1.345
Qtrly Earnings Growth
Operating Cash Flow (M) -31
Levered Free Cash Flow (M) 33

Stock Valuations

PE Ratio -29.77
PEG Ratio
Price to Book value 3.44
Price to Sales 10.83
Price to Cash Flow -73.32

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.